Login / Signup

Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol.

Dale TerasakiChristopher SmithSusan L Calcaterra
Published in: Pharmacotherapy (2019)
A protocol using microdosing of buprenorphine can successfully transition patients receiving full μ-opioid agonist therapy, including methadone, to buprenorphine without the need for a period of opioid abstinence.
Keyphrases
  • chronic pain
  • pain management
  • randomized controlled trial
  • bone marrow
  • cell therapy